2026 is the year the price of semaglutide started falling in Canada. Health Canada approved the first generic version of Ozempic around April 28, 2026, and on June 29 it approved Sevmia — a generic equivalent of Wegovy for weight management, from Apotex, for ages 12 and up. More generics are in the queue.
For a drug class that has cost hundreds of dollars a month, that is a big deal. Here is what Sevmia and the generic-semaglutide wave actually mean for Canadians, what they cost, and the catches worth knowing.
What Sevmia is
Sevmia is a generic version of Wegovy — same active ingredient, semaglutide — approved by Health Canada on June 29, 2026 for weight management in people aged 12 and older. It is made by Apotex, a large Canadian generic manufacturer, and it is the third generic semaglutide product cleared in Canada.
“Generic” means it contains the same active drug as the brand, at the same strength, and has been judged equivalent by Health Canada — but it is sold without the brand name and, crucially, at a lower price. Wegovy and Sevmia are the weight-management side of semaglutide; Ozempic is the diabetes brand of the same molecule. We cover the diabetes side in generic Ozempic in Canada.
The science of semaglutide hasn’t changed. What changed in 2026 is the price — and in Canada, price is the thing that kept most people off these drugs.Why the generics matter
The generic semaglutide timeline
2026 moved fast. The short version of how Canada got here:
- ~April 28, 2026: Health Canada approved the first generic version of Ozempic (the diabetes brand of semaglutide).
- May 19–21, 2026: generics began reaching pharmacies. Apotex started shipping around May 19 at roughly a third of the brand price; Dr. Reddy’s product arrived the same week. The online platform Felix listed semaglutide at about $150 a month from May 21.
- June 29, 2026: Health Canada approved Sevmia (Apotex), the generic equivalent of Wegovy for weight management, for ages 12 and up — the third generic semaglutide approved, with six more submissions reported under review.
In short: the diabetes generic came first, the weight-management generic (Sevmia) followed, and the pipeline suggests still more are coming.
What it costs
Brand-name weight-management semaglutide has run high — experts put brand Wegovy at roughly $400 a month. Generics are designed to undercut that significantly.
- Early generic semaglutide reached pharmacies at about a third of the brand price, and one online platform listed it near $150 a month.
- Under Canada’s pan-Canadian Pharmaceutical Alliance (pCPA) rules, the generic price drops to at least 50% below the brand once two generics are on the market — and more are arriving.
Exact prices vary by product, pharmacy and whether you have coverage, but the direction is clear: semaglutide is getting a lot cheaper in Canada.
Ozempic vs Wegovy vs generic
People mix these up constantly, so here is the clean version:
| Name | What it is | Approved for |
|---|---|---|
| Ozempic | Brand semaglutide (Novo Nordisk) | Type 2 diabetes |
| Wegovy | Brand semaglutide, higher-dose weight product | Weight management |
| Sevmia | Generic semaglutide (Apotex) | Weight management (ages 12+) |
| Generic Ozempic | Generic semaglutide | Type 2 diabetes |
All four are the same molecule — semaglutide — packaged and approved for different uses. Sevmia is simply the generic that competes with Wegovy on the weight-management side.
The catches
A few things worth knowing before assuming the price drop solves everything:
- Coverage still varies. Provincial and private plans decide reimbursement separately, so many early buyers pay cash even with a generic on the shelf.
- Substitution rules differ. Pharmacists may substitute a generic for brand Ozempic in many cases, but weight-management products can follow different rules.
- Supply and demand. These drugs have seen shortages; a cheaper price can increase demand faster than supply.
- It is still a prescription drug. Semaglutide, generic or brand, requires a prescription and medical supervision. This is not something to source outside the system.
Cheaper generics do not change the fact that these are prescription medicines. Health Canada’s 2026 advisory was blunt that unauthorized injectable peptides sold online are illegal and that a “research use only” label gives no exemption. A real prescription for an approved generic is the legal, safe route — talk to your doctor or pharmacist.
What comes next
Three trends to watch. First, more generics: with several submissions under review and manufacturers like Sandoz preparing launches, prices should keep falling through 2026 and beyond. Second, the pill: an oral version of semaglutide for weight loss was approved by the FDA in late 2025, and Novo Nordisk has applied to Health Canada. Third, the next generation: drugs like tirzepatide and the investigational retatrutide promise larger weight loss, and we map the whole field in the next weight-loss drugs after Ozempic.
Myths
“Myth: Generic semaglutide is weaker than the brand.”
A Health Canada-approved generic contains the same active ingredient at the same strength and is judged equivalent to the brand. The difference is price and name, not potency.
“Myth: Sevmia and Ozempic are different drugs.”
Both are semaglutide. Ozempic is the diabetes brand; Sevmia is a generic for weight management (the Wegovy side). Same molecule, different approved use and price.
“Myth: Now that it’s cheap, I can buy it without a prescription.”
No. Semaglutide is a prescription drug in Canada regardless of price. Buying unauthorized injectable versions online is illegal, and a research-use label does not change that.
“Myth: A generic means my insurance will now cover it.”
Not automatically. Coverage is decided by each provincial and private plan separately, so many people still pay out of pocket even when a cheaper generic exists.
For researchers
TrueLabs does not sell semaglutide, Sevmia or any human medicine — these are prescription products you access through a pharmacy. TrueLabs supplies research-grade reference peptides in CAD, for in vitro and laboratory research only, never for human or veterinary use, including next-generation metabolic compounds such as RT3 (retatrutide) from $90 and TZ-2 (tirzepatide) from $73. For what quality documentation should look like, see how to read a peptide COA and the COA library.
FAQ
Tap a question to reveal the answer.
What is Sevmia?
Sevmia is a generic version of Wegovy (semaglutide) for weight management, made by Apotex and approved by Health Canada on June 29, 2026 for ages 12 and up. It is the third generic semaglutide cleared in Canada.
Is generic semaglutide available in Canada?
Yes. Health Canada approved the first generic Ozempic (diabetes) around April 28, 2026, with generics reaching pharmacies in May, and Sevmia (generic Wegovy, weight management) on June 29, 2026. More are under review.
How much does generic semaglutide cost in Canada?
Early generics reached pharmacies at roughly a third of the brand price, with one online platform listing about $150 a month. Under pCPA rules the price falls to at least 50% below the brand once two generics are on the market. Exact cost depends on the product, pharmacy and your coverage.
Is Sevmia the same as Ozempic?
Both are semaglutide, but Ozempic is the brand for type 2 diabetes while Sevmia is a generic for weight management (the Wegovy side). Same molecule, different approved use.
Do I still need a prescription for generic semaglutide?
Yes. Semaglutide is a prescription drug in Canada whether brand or generic. It requires a prescription and medical supervision; buying unauthorized injectable versions online is illegal.
Will my insurance cover Sevmia?
Maybe. Provincial and private plans decide coverage separately, so some people pay cash even with a generic available. Check your specific plan.
Is there a semaglutide pill in Canada?
An oral version of semaglutide for weight loss was approved by the FDA in late 2025, and Novo Nordisk has applied to Health Canada. As of October 2026 the Canadian decision was still pending.
Is a cheaper generic as safe as the brand?
A Health Canada-approved generic meets the same standards for the active ingredient as the brand. Side effects are the same class effects as any semaglutide. Discuss suitability with your doctor or pharmacist.
Related reading
- Generic Ozempic in Canada
- The next weight-loss drugs after Ozempic
- What is retatrutide?
- CagriSema vs retatrutide
- Peptides for weight loss
References
- Canada approves generic version of Wegovy for weight loss (Sevmia, June 29, 2026). Chronicle Journal / Canadian Press. Chronicle Journal
- Health Canada approves first generic version of Ozempic (April 28, 2026). BNN Bloomberg. BNN Bloomberg
- Generic semaglutide to hit Canadian pharmacies at a fraction of the cost of Ozempic (May 20, 2026). BNN Bloomberg / Canadian Press. BNN Bloomberg
- Health Canada. Think twice before injecting peptides bought online (advisory, April 9, 2026). Health Canada
This article summarizes published regulatory and news information for information only and is not medical advice. TrueLabs research compounds are sold for in vitro and laboratory research use only and are not intended for human or veterinary use.